Rachel M. Holden
Papers
3
Total Citations
22
H-Index
3
About
Dr. Rachel M. Holden is a pioneering researcher at the intersection of nephrology and neuropsychology, whose work has fundamentally advanced our understanding of how kidney disease affects brain function. Her research focuses on the neurocognitive consequences of acute kidney injury (AKI) and chronic kidney disease (CKD), with particular emphasis on perceptual-motor, visuospatial, and executive function impairments. Dr. Holden’s major contribution lies in her innovative use of robotic technology to objectively quantify subtle neurocognitive deficits that traditional testing fails to capture—a methodological breakthrough that has opened new avenues for early detection and intervention. Her most cited paper (2021, 12 citations) established that even mild AKI is associated with quantifiable neurocognitive impairments, while her subsequent work (2022) employed multilevel modeling to demonstrate progressive visuospatial and executive dysfunction across the full spectrum of kidney disease, from AKI to kidney failure. With a growing citation impact, Dr. Holden’s research is reshaping clinical understanding of the brain-kidney axis and providing critical tools for improving quality of life in patients with renal disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3